Metagenics, Inc.

Metagenics, Inc. is a health-focused company that specializes in developing high-potency dietary supplements and vitamins, aimed at supporting overall wellness for individuals through science-backed nutritional solutions. Founded in 1983 and headquartered in Aliso Viejo, California, Metagenics, Inc. focuses on providing nutritional products to enhance health and wellness.

The company was acquired in October 2021 by Gryphon Investors and its management from Alticor Inc. , which marked a strategic shift to enhance product distribution. The leadership team includes Brent Eck, Ivan Soto, Jim Shaddle, and Pat Smallcombe. Metagenics has completed three deals to date, with its most recent funding round being a Growth round, raising USD 11.

00 mn, which is the total amount raised. Metagenics specializes in high-potency dietary supplements and vitamins that support various aspects of health and wellness for both men and women. The product range includes supplements targeting energy, immunity, hormonal balance, and digestive health. Notably, their HerWellness collection addresses women's health issues, particularly during perimenopause and menopause, focusing on alleviating symptoms like irritability and fatigue.

Metagenics provides these products to healthcare practitioners who recommend them to patients, serving a clientele that includes both professionals and consumers seeking effective nutritional solutions. Their market reach spans North America, Europe, and parts of Asia, ensuring accessibility for a diverse international customer base. Metagenics generates revenue primarily through direct sales channels including healthcare practitioners, retail partnerships, and e-commerce platforms. Products are offered via a structured transaction model allowing healthcare providers to purchase supplements at wholesale prices for their practices, alongside direct-to-consumer sales through their website.

Flagship products, such as high-absorbable magnesium and various probiotics, drive sales, targeting specific health needs prevalent among consumers. Revenue is further enhanced through subscription services and strategic partnerships that provide healthcare providers with educational resources and marketing support, maintaining competitive pricing for both practitioners and consumers. Metagenics, Inc. plans to leverage the recent acquisition to enhance its ability to provide and distribute effective nutritional solutions for healthcare and customers.

Future initiatives include the launch of new products designed to meet evolving health needs, although specific release dates have yet to be disclosed. The company aims to expand its market presence into new geographic regions, although specific targets have not been outlined. The recent funding received in the Growth round will support these initiatives, enabling Metagenics to continue developing and distributing innovative products within the healthcare industry.